TOVX icon

Theriva Biologics
TOVX

Overview Fund Trends Analyst Outlook Journalist POV

32 hedge funds and large institutions have $3.18M invested in Theriva Biologics in 2022 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

11% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 9

Holders
32
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$80K
2
+$43.2K
3
+$38K
4
HF
HRT Financial
New York
+$29K
5
Northern Trust
Northern Trust
Illinois
+$26K

Top Sellers

1
-$299K
2
-$76K
3
-$65.9K
4
IA
IFP Advisors
Florida
-$34.7K
5
BCM
Bridgeway Capital Management
Texas
-$20K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$3K
27
$1K
28
–
29
–
30
–
31
–
32
–
33
–
34
–
1
2